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Abstract
Introduction
Individuals and communities affected by NTDs are often the poorest and most marginalised;
ensuring a gender and equity lens is centre stage will be critical for the NTD community to
reach elimination goals and inform Universal Health Coverage (UHC). NTDs amenable to
preventive chemotherapy have been described as a ‘litmus test’ for UHC due to the high
mass drug administration (MDA) coverage rates needed to be effective and their model of
community engagement. However, until now highly aggregated coverage data may have
masked inequities in availability, accessibility and acceptability of medicines, slowing down
the equitable achievement of elimination goals.
Methods
We conducted qualitative programmatic analysis across different country contexts through
the novel application of the Tanahashi Coverage Framework enhanced by gendered
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COUNTDOWN was formed in 2014 and is funded
intersectional theory to interrogate different components of programme coverage: availabil-
ity, accessibility, acceptability, contact and effective. Drawing on communities and health
implementers perspectives (using focus groups, interviews, and participatory methods)
from varying levels of the health system, across four African country contexts (Cameroon,
Ghana, Liberia and Nigeria), we show who is left behind and provide recommendations for
programmes to respond.
Findings
We have unmasked inequities in programme delivery that repeatedly leave vulnerable pop-
ulations underserved in relation to the prevention and treatment of PC NTDs across all com-
ponents of coverage explored within the Tanahashi framework. Inequities are influenced by
health systems challenges and limitations, due to lack of consideration of gender, power
and equity issues. Effective treatment for individuals and communities is shaped by individ-
ual identities and the intersecting axes of inequity that converge to shape these positions
including gender, age, disability, and geography. Health systems are inherently social and
gendered thus they become mediators in managing the impact that social and structural pro-
cesses have on individual health outcomes.
Significance
To our knowledge this is the only paper which has combined a comprehensive equity frame-
work with intersectional feminist theory, to establish a fuller understanding of who is left
behind and why in MDA across countries and contexts. Ensuring the most vulnerable have
continued access to future treatment options will contribute to the progressive realisation of
UHC, allowing the NTD community to continue to support their vision of being a true ‘litmus
test’.
Author summary
Individuals and communities affected by Neglected Tropical Diseases (NTDs) are often
the poorest and most marginalised. Some NTDs (lymphatic filariasis, onchocerciasis, soil
transmitted helminths, schistosomiasis and trachoma) have been given specific targets for
control and elimination by the year 2020. Reaching these goals is important for the attain-
ment of Universal Health Coverage (UHC) as well as the Sustainable Development Goals
and has been described as a litmus test. However, few studies have considered how fair
progress toward attainment of these goals has been to date. We used qualitative research
methods to explore the equity of progress toward these targets across four countries
(Ghana, Cameroon, Liberia and Ghana). We used a framework for assessing health ser-
vices coverage (The Tanahashi Framework) and combined it with gendered intersectional
theory (a theory that helps us think about how individuals position of power and privilege
shape their experience) to understand who is left behind and why in NTD programme
delivery. We found that health systems challenges and limitations due to lack of consider-
ation of gender and equity issues have left vulnerable populations underserved in relation
to the prevention and treatment of PC NTDs. Key steps need to be taken at different
health system levels to ensure the most vulnerable have continued access to future
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treatment options. This will contribute to the attainment of UHC, allowing the NTD com-
munity to continue to support their vision of being a true ‘litmus test’.
Introduction
Globally and nationally efforts to address Neglected Tropical Diseases (NTDs) have had many
successes but new approaches and analyses are required to equitably attain defined targets and
elimination goals. Individuals and communities affected by NTDs are often the poorest and
most marginalised; ensuring a gender and equity lens is centre stage will be critical if the NTD
community will reach elimination goals, inform Universal Health Coverage (UHC) and ensure
no-one is left behind in contributing toward the 2030 United Nations Sustainable Develop-
ment Goals (SDGs)[1, 2]. NTDs amenable to Preventive Chemotherapy (PC), through Mass
Drug Administration (MDA), (including lymphatic filariasis, onchocerciasis, schistosomiasis,
soil transmitted helminths and trachoma) have frequently been the focus of control and elimi-
nation targets in relation to NTDs[3]. PC-NTDs have been described as a ‘litmus test’ for UHC
due to the high MDA coverage rates needed to be effective and their model of community
engagement for access and acceptance of medicines [4, 5]. MDA campaigns globally have
demonstrated their ability to reach communities viewed by other health providers as ‘hard to
reach’ and so are included as a key equity tracer within the SDGs [4, 6, 7]. However, until now
highly aggregated MDA coverage data may have also masked inequities in availability, accessi-
bility and acceptability of medicines, slowing down the equitable achievement of elimination
goals and even exacerbating health inequalities [8].
There is growing interest and awareness of the importance of better understanding and
addressing inequities in global health including how health systems are structured, the utilisa-
tion of health services and in experiences of (ill) health and well-being [9, 10]. This is reflected
in the current UHC movement which seeks to establish mechanisms to achieve progressive
UHC, through the provision of a package of essential services guided by need and prioritised
on reaching the most vulnerable first as opposed to an extension of routine health services
[11]. This focus has extended to NTDs with recent analysis of the opportunities posed by gen-
der mainstreaming for NTDs [8]; the development and testing of a toolkit on gender, equity
and rights within NTD programming by the WHO [7] and an analysis of quantitative data sets
from 16 countries that demonstrated that reporting gender disaggregated data is feasible how-
ever understanding gendered barriers remains a priority [12]. A global burden of disease study
also highlighted differences in Disability Adjusted Life Years (DALYs) by age and gender [13].
Gender however, as a socially constructed concept, varies through space, contexts and time as
individuals construct differing roles and identities shaped by broader political, sociocultural
and economic factors [14–16]. Therefore focusing on gender in isolation of other intersecting
axes of inequity will not be enough to ensure equitable health care delivery [8, 17]. Further-
more, there is a need to better understand commonalities and differences in experience across
diverse and changing contexts such as increased levels of urbanisation, migration and fragility
[18–22].
Ongoing equity analysis is clearly not only ethical but essential in monitoring the attain-
ment of UHC including in NTDs. There are many tools and frameworks which aim to pro-
mote equity analysis and action. The Tanahashi Framework [23] (see Fig 1), a comprehensive
framework which demonstrates how, at each coverage level, various factors within the health
system work together to influence who has access to services with the potential to lose people
at each stage [23, 24]. Thus, the use of the term coverage in the Tanahashi Framework is
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slightly different to the common use of the term coverage within PC-NTD programmes. How-
ever, the different types of coverage referred to within the Tanahashi framework all contribute
to the attainment of ‘drug coverage’ (i.e. the number of persons receiving PC divided by the at-
risk population or the eligible population) commonly reported by PC-NTD programmes.
Despite being relatively old, the 1978 Tanahashi Framework has gained new momentum in
facilitating equity analysis supporting the breakdown of various health systems elements that
contribute to quality and effective service delivery whilst also unpacking equity concerns at
each stage [24]. The five coverage domains that the model draws upon (availability, accessibil-
ity, acceptability, contact, and effective coverage) are appropriate for analysing equitable NTD
programme delivery which relies on various components of the health system pulling together
to ensure that as many people as possible are in receipt of associated medicines[7, 24] and that
the best and most equitable ‘drug coverage’ is attained.
Coverage frameworks alone, do not allow for in-depth exploration of how power shapes
underlying context specific social and structural processes that determine who and how certain
individuals and populations move up the coverage ladder whilst others are left behind. Gender
as one axis of social advantage or disadvantage that can shape marginalisation and impact
health is an essential consideration alongside the use of existing coverage frameworks. Gender
in isolation however is limiting and we must consider how other individual (e.g. age and dis/
ability) and social (e.g. environmental infrastructure) factors interact to shape inequities in ser-
vice access [20]. Intersectionality seeks to ‘move beyond single or typically favoured categories
of analysis (e.g. sex, gender, race and class) to consider simultaneous interactions between dif-
ferent aspects of social identity, as well as the impact of systems and processes of oppression
and domination” [25 p3] and is a theory that is increasingly being drawn upon in global health
[26, 27]. Intersectionality is not additive, rather it considers how human and social characteris-
tics such as age, gender, sex, ability, disability, race, ethnicity, sexuality etc. interact to shape
individual experience at a given point or time. To date, intersectional approaches have not
been applied to NTDs; this is a missed opportunity given the importance of thinking critically
Fig 1. The Tanahashi Framework- an illustration of the links between attainment of service delivery goals and ‘types’ of
coverage.
https://doi.org/10.1371/journal.pntd.0007847.g001
Neglected Tropical Diseases as a litmus test for Universal Health Coverage?
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0007847 November 21, 2019 4 / 26
about programme delivery through time and space, the role of power, how decisions are made
and the impacts of these on individuals and communities facing multiple and intersecting
marginalities.
The primary aim of this paper is to present qualitative programmatic analysis across differ-
ent country contexts and apply the Tanahashi Framework intertwined with gendered intersec-
tional theory to interrogate different components of programme coverage. Drawing on
perspectives of communities and health implementers from varying levels of the health system
across four African country contexts (Cameroon, Ghana, Liberia and Nigeria) our key objec-
tive was to understand who is left behind and why within current PC-NTD programming, to
allow programmes to think differently about who is not reached and why and to respond. This
cross-country study was completed as part of the research programme consortia COUNT-
DOWN a five-year Department for International Development (DFID) funded project which
brings together innovative and multi-disciplinary NTD researchers, policy makers and practi-
tioners to conduct implementation research to produce evidence to contribute to reducing the
morbidity, mortality and poverty associated with NTDs [28].
Methods
NTD control programmes and research on NTDs has primarily focused on programmatic cov-
erage data and other quantitative data sets [29, 30]. Broad data sets can miss unseen or
neglected populations and arguably mask specific gender, access and equity issues as they are
limited in their ability to provide insights into the norms, processes and relations which shape
practice and bring solutions for change [7]. We aimed to specifically understand the experi-
ences, voices and perspectives of communities affected by NTDs, front line providers includ-
ing Community Drug Distributors (CDDs), teachers and programme managers and hence
chose a range of qualitative methods.
Study settings
The four country contexts were selected as they are the COUNTDOWN partner countries,
and each represent different points in the NTD control and elimination journey. Ghana and
Cameroon are in latter phases of disease control and elimination for many of the PC NTDs
and are moving toward more targeted treatment strategies for ‘hot spot’ areas where there are
unexpectedly high levels of ongoing disease transmission. Liberia is comparatively in the ear-
lier stages of disease control and elimination and Nigeria faces the ongoing challenge of how
to scale-up the provision of MDA to such a large and diverse population.
Data collection
Qualitative methods, including key informant interviews, in-depth interviews, focus group dis-
cussions and a range of participatory methods (including transect walks, social mapping, sea-
sonal calendars and photovoice) were utilised with purposively selected participants based on
the overall COUNTDOWN protocol and adaptations that were made to context. Table 1 gives
an overview of which methods were used, with which participants in which contexts. A further
breakdown of data and participants can be found in supplementary file one. Variation in
methods across contexts enabled triangulation of the findings between type of method, partici-
pant group and country context. In all country teams, qualitative data were collected by experi-
enced social scientists in each country who received additional training on trustworthiness in
the qualitative research cycle and (where appropriate) the context of NTDs.
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Table 1. Overview of methods used by context.
Country
Context
Study Site(s) within
Country
Method Used Description of Method Number
Ghana Nzemah East; Ellembelle;
West Gonja; Bole-Bamboi
districts
In-depth interviews Face to face individual interviews were conducted with
programme implementers at varying levels of the health system to
explore their perspective on the successes and challenges of MDA
implementation with focus on identifying what will work in the
elimination of LF in Ghana.
Individual interviews were also conducted with people who did
and did not take MDA within communities to understand
reasons for their attitude and practices regarding MDA.
67 interviews
18 interviews
Ghana Nzemah East; Ellembelle;
West Gonja; Bole-Bamboi
districts
Focus Group Discussions Focus group discussions were conducted with different groups of
community members based on gender and age to explore general
perceptions of MDA and community roles in eliminating LF.
34 focus groups (351
participants)
Ghana Nzemah East; Ellembelle;
West Gonja; Bole-Bamboi
districts
Seasonal Calendars Seasonal Calendars were used to explore the effect of population
livelihood activities, seasonality and migration on MDA. Separate
groups were conducted with men, women and adolescent males
and females.
24 seasonal calendars
(264 participants)
Ghana Shai-Asudoku and Ga
South
In-depth Interviews and
Focus Group Discussions
Face to face individual and group interviews with health workers,
adolescent males and females, adult females and males, teachers
and community opinion leaders to explore community
understanding of schistosomiasis and STH and the feasibility and
acceptability of community wide MDA for Schistosomiasis.
30 interviews
7 focus group
discussions (78
participants)
Ghana Shai-Asudoku In-depth Interviews, Focus
Group Discussions and
Vignettes
The participatory vignette method was used to explore
community knowledge and experiences on FGS. Participants
included in-school and out of school adolescent males and
females.
Participants for focus group discussions and in-depth interviews
were selected on gender and age group basis from the community
and the health system. Adolescent females who ever had genital
schistosomiasis, community leaders, local medicine sellers,
traditional birth attendents, teachers, pupils, health providers,
adult males and females were included. To explore community
and health provider knowledge and understanding of female
genital schistosomiasis and identified potential strategies for
giving a voice on the disease to improve the reproductive health
needs of women/girls.
34 interviews
11 focus group
discussions (99
participants)
6 vignettes (48
participants)
Ghana Ellembelle Photovoice The process involved community drug distributors (CDDs)
trained to photograph their everyday work and realities during
MDA; then composed written and verbal narratives to
accompany the photographs. The purpose of the study was to
understand the everyday experiences of the CDDs and the
possible impact on their roles in programme implementation.
Three (3) females and two (2) males were involved.
5 participants for
photo voice
Nigeria Kaduna and Ogun State Key Informant Interviews Key Informant Interviews regarding strengths and weaknesses of
ongoing programme implementation with programme
implementers at the State and Local government level.
43 interviews
Nigeria Kaduna and Ogun State
(urban and rural LGAs)
Participatory Stakeholder
Meetings
A series of stakeholder meetings with frontline implementers
(CDDs, Teachers, and Frontline Facility Health Staff) that drew
on participatory methods to identify challenges to programme
implementation and suggest solutions to overcome challenges.
30 stakeholder
meetings (330
participants)
Nigeria Kaduna and Ogun State
(urban and rural LGAs)
Transect walk Transect walks through the most common route in the
community were conducted with influential community
members to understand current and potential MDA distribution
structures and who is and isn’t reached using these structures.
16 transect walks (77
participants)
Nigeria Kaduna and Ogun State
(Urban and rural LGAs)
Focus Group Discussions Focus group discussions were held with frontline implementers
(CDDs, Teachers, and Frontline Facility Health Staff) to identify
the challenges with training and how best to improve training
delivery for MDA.
24 focus group
discussions (135
participants)
(Continued)
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Table 1. (Continued)
Country
Context
Study Site(s) within
Country
Method Used Description of Method Number
Nigeria Kaduna and Ogun State
(Urban and rural LGAs)
Social Mapping Social mapping was conducted with community members in
groups separated by gender and age. Social mapping involved
asking community groups to draw a map of their community
identifying key places where key steps in the MDA process
(sensitisation, mobilisation, medicine distribution) currently
takes place or could take place in the community and who would
be or is engaged in these places.
48 social maps (361
participants)
Nigeria Kaduna and Ogun State
(Urban and rural LGAs)
Focus Group Discussions Focus group discussions were held with community members in
groups separated by age and gender to elicit feedback on the best
way to communicate messaging and information about the
programme.
43 focus group
discussions (211
participants)
Nigeria Kaduna Focus Group Discussions Focus group discussions were held with groups of community
members and CDDs to explore experiences of programme
delivery in relation to accessibility and acceptability of the MDA
intervention.
9 focus group
discussions (90
participants)
Liberia National, Maryland and
Bong County
Key Informant Interviews Key informant interviews were conducted with NTD programme
implementers at different levels of the health system to explore the
realities of MDA implementation from a health systems
perspective and focused on what helps and hinders the
programme with specific reference to financing, leadership and
governance, health workforce and service delivery.
13 interviews
Liberia Maryland and Bong
County
Life and Job Histories Life histories were used to explore CDDs’ life and career history
and elucidate their motivations for the work they do, training they
have received, and the ways in which they are supported to fulfil
their role. The purpose of these interviews was to understand
current levels of job satisfaction and level of engagement with the
NTD programme to be able to assess what strategies could be
utilised to better support CDDs.
42 life and job histories
Liberia Maryland and Bong
County
Focus Group Discussions
including Social Mapping
Focus Group Discussions were conducted with community
members to explore general perceptions of Mass Drug
Administration (MDA) as well as health communication
preferences. FGDs incorporated the use of participatory social
mapping to explore community structures (physical and social)
that are currently used or could be better used in NTD
programme delivery. Separate groups were completed with men,
women and youth and influential community members (also
separated by gender).
21 focus group
discussions (164
participants)
Liberia Maryland and Bong
County
In-depth Interviews with
community members
In-depth interviews were conducted with purposively selected
community members to understand their knowledge, perceptions
and experiences of existing MDA strategies.
40 interviews
Liberia Maryland County In-depth interviews with
parents of school aged
children
In-depth interviews were completed with purposively selected
parents of school aged children to understand their knowledge,
perceptions and experiences of existing MDA strategies for
Schistosomiasis. Mothers and fathers were interviewed separately
but as ‘sets’ to try and understand variation in view points and
decision making within one household.
19 interviews
Cameroon South-West Region
(Mbonge, Kumba and
Bafia Health District)
In-depth interviews In-depth interviews were conducted with community members to
understand their knowledge, experiences and perceptions of
onchocerciasis, and experiences of community directed treatment
with Ivermectin. The Data captured information from different
categories of participants: acceptors and refusers of ivermectin
and CDDs, Chiefs of Centres, person living with NTDs, family
member of person living with NTDs, and community leaders.
121 interviews
Cameroon South-West Region
(Bafia Health District)
Key Informant Interviews Key informant interviews were conducted with influential
community members (leaders of associations and community
leaders) to capture their views on how community directed
treatment with ivermectin functions in their communities.
6 interviews
(Continued)
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Data analysis
Once collected, data were transcribed verbatim into English and then audio recordings com-
pared to transcripts to check for accuracy in translation by a second reviewer. Data were then
analysed using a thematic framework approach [31] within country specific qualitative
research teams with support and inputs from specifically trained qualitative researchers within
the broader COUNTDOWN consortium. Data were then synthesised, and an analytical
account produced to highlight core strengths and weaknesses of the respective programmes
with a specific focus on understanding challenges in ensuring equity and access in programme
delivery. Where possible initial analyses have been shared and discussed with NTD pro-
gramme managers leading to some lively interactive sessions. Paper writing workshops, con-
sortium meetings (which brought together researchers from the four country contexts and
across the COUNTDOWN partnership) and skype and email exchanges allowed joint analysis
across the different domains of the Tanahashi framework and a critical discussion of how gen-
der and other axes of inequity intersect to shape and limit equity of access to MDA. The analyt-
ical account is presented below under the core areas of the Tanahashi Framework.
Ethical considerations
Prior to data collection ethics approval was obtained from the: Liverpool School of Tropical
Medicine (15.043); Ghana Health Service ERC and Dodowa Health Research Centre IRB;
National Health Research Ethics Committee of Nigeria (approval no NHREC/01/01/2007-19/
12/2017); Cameroonian National Ethics Committee for Research on Human Health (approval
no. 2016/11/838/CE/CNERSH/SP), and the Division of Health Operations Research within
the Cameroonian Ministry of Public Health (approval no. 631–03.17); and University of Libe-
ria Pacific Institute for Research and Evaluation IRB (16-09-009). Written or verbal informed
consent was taken from all participants prior to inclusion in the study. Confidentiality has
been maintained within data collection, analysis and dissemination (including in the presenta-
tion of quotes) through the removal of all identifiable information from transcripts and analy-
sis accounts. All data were collected in private spaces that were acceptable to participants and
secure data storage that included separation of consent forms from other data was used.
Where the job role of specific health cadres may have made them identifiable due to the
Table 1. (Continued)
Country
Context
Study Site(s) within
Country
Method Used Description of Method Number
Cameroon South-West Region
(Bafia Health District)
Focus Group Discussions
with Community Members
Focus Group Discussions were conducted with community
members to capture their experience and perceptions of the
community directed treatment with ivermectin
6 focus group
discussions (55
participants)
Cameroon South-West Region
(Bafia Health District)
Focus Group Discussions
with CDDs
Focus Group Discussions were conducted with CDDs to capture
their roles, motivation and perceptions of the community
directed treatment with ivermectin
3 focus group
discussions (18
participants).
Cameroon South-West Region
(Barombi Kotto and
Barombi Mbo Health
District)
Littoral Region
(Edea Health District)
Centre Region
(Makenene and Yaounde
Health District)
Key Informant Interviews
In depth interviews
Key informant and in-depth interviews were conducted with key
stakeholders at all operational levels of PC-NTD programme
delivery (specifically in relation to schistosomiasis, STH and
onchocerciasis). The purpose of the interviews was to identify
bottlenecks and strengths in existing programme strategies and
their implementation to support in designing the way forward for
MDA scale up.
163 interviews
https://doi.org/10.1371/journal.pntd.0007847.t001
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minimal numbers or men/women in specific cadres at specific levels of the health system, we
took extra care to discuss the way the data were presented with these participants and chose
not to report sex, age or specific job role where necessary.
Results
Context and commonality: Donor dependency, privilege and oppression,
fragility and programme legacy
From an intersectional perspective, it is important to position inequities within geographic
contexts and to better understand the political, historical and institutional (health systems and
programmatic) trajectories that shape current practice. From our analyses there were many
similarities which emerged across all country contexts. One key similarity is the aid depen-
dency and vertical funding streams for different NTDs that impact on programme functioning
by limiting both flexibility and autonomy of national NTD programmes.
‘The donor tells us first, ‘here are my priorities, here is the amount that I can give you. . .Now,
you take his priorities as you go into activities . . . there may be [other] activities that are even
relevant, but because there are no resources, we will not finance’. . . (NTD implementing part-
ner official, male, IDI, Cameroon)
Disjointed funding streams and a lack of co-ordination between funders and implementing
partners exacerbates inequities; for example, cross-border gaps in distribution can result in
some communities being missed during MDA campaigns. Illustrative quotes are provided in
the subsequent sections to further support this.
Another commonality is that each country context has the challenges of hidden, hard to
reach, vulnerable and marginalised individuals and populations (geographically, socially and
politically) who face extreme poverty and in some cases conflict and fragility. The levels of fra-
gility shapes context in multiple ways. Liberia’s historic fragility based on conflict and the
Ebola epidemic has brought multiple challenges (and opportunities) for the NTD programme.
Pockets of recent and ongoing conflict are also occurring in both Cameroon (in the South
West Anglophone areas) and Nigeria (mainly in the North and the Niger Delta) and have wide
reaching impact on the programme and communities.
Programme legacy matters both from a programmatic perspective and from the views and
memories of communities. In Cameroon, where onchocerciasis co-exists with Loa Loa, previ-
ous Ivermectin distribution resulted in severe adverse events including some deaths which has
presented long term challenges for programmes and community acceptance of other PC NTD
drug acceptance. In Nigeria, Cameroon, and Ghana there is a long and sustained history of
programme delivery which has obtained many successes. However, through time in all con-
texts, the initial onus on community directed approaches and flexibility in response has argu-
ably lessened due to both donor dependency/inflexibility and the bureaucratisation/
normalisation of approaches.
Availability coverage
Availability coverage is concerned with ensuring that all services are available to those who
require it within a given population, this requires adequate staffing and resources so that the
maximum capacity of the service is not limited[23]. Across all contexts, availability coverage
was negatively impacted due to staff limitations, medicine shortages and delays in the supply
chain leading to equity challenges with some populations being untreated. Over time, updating
the community census prior to MDA distribution has ceased in some areas resulting in
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inaccurate drug requisition requests based on outdated population estimates. Coupled with
poor supply chain management, particularly within Nigeria and Liberia, this frequently
resulted in localised drug shortages and therefore specific populations being untreated, in
some cases decided by political affiliations or relationship with the distributer. Those untreated
included people perceived as ‘outsiders’ to communities e.g. migrant communities, and those
from different ethnic or religious backgrounds to the majority in specific settlements (for
example Nigerian communities in Cameroon) or simply those most remote and furthest from
the health facility who got treated last.
In relation to school-based distributions, where schools were large or when the programme
did not engage with particular schools (for example Islamia/ Almajiri schools in Nigeria, and
private schools in Nigeria and Cameroon) children often went untreated. Out of school chil-
dren were a population that are particularly hard to reach across all contexts. In Liberia, where
more children are out of school than in school, this had led to an adaption of distribution
mechanisms to community-based processes to reach coverage targets. In Cameroon, some
schools chose to encourage out of school children to come and collect medicines on distribu-
tion days but found this still left out many children, stressing the importance of community-
based distribution. In Cameroon and Nigeria, teachers expressed a need for stronger support
from and links with community drug distributers and the health system to increase parental
trust of medicines distributed by teachers and to handle side effects.
‘. . .the main bottleneck is private schools. Very few private schools take part in deworming
campaigns. . .when the child is not in school, it becomes complicated for us. It’s true that we
insist if a child doesn’t attend classes in a school and presents himself on the day of distribu-
tion, he should not be denied treatment. But still, it is hard to imagine a child coming to a
school which he doesn’t belong to, especially in our schools that have fences.’ (Regional Educa-
tion official, male, KII, Cameroon)
‘Some children came from the community asking for the medicine, but we didn’t have much
for them only few of them got because we were instructed to focus on the school enrolled chil-
dren’ (Teachers, FGD, Kaduna State, Nigeria).
Likewise, in southwest Cameroon schools (primary and secondary) in 20 intervention com-
munities have been closed for over three years due to conflict, so programmes have responded by
undertaking community-based distribution which has increased availability. Where drug supply
did not meet demand, this often-compromised trust between health and education systems and
the communities they were serving. In many cases, CDDs, teachers and health facility staff would
do all they could to obtain medicines to reach those currently missed by using their own monies
to travel large distances to replenish medicine stocks and follow up those who were previously
untreated, this could be impoverishing for implementers. In Ghana, localised drug shortages were
uncommon, however staff shortages in some areas hindered some populations (particularly those
living in small settlements far from each other) from receiving medicines.
‘Look we have so much drugs with us here, this is even from the last two distribution cycle.
The problem is that we do not have enough CDDs to distribute these drugs. We can only use
few CDDs because the program says there is no money. That is why some people are complain-
ing of not receiving them’ (Subdistrict health staff, Ghana).
‘I find difficulty in that money does not flow for me, that is, when I want to go and get the
Mectizan I stress a lot . . .The little money that I would have used to eat I use it instead to pay
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the transportation to and fro when I want to go and take Mectizan and also when I want to
return it.’ (CDD, Male, IDI, Cameroon)
In Cameroon and Liberia, there were reports from community members and CDDs that
historically, medicines were sometimes kept for selling by various actors within the health sys-
tem, including CDDs and frontline health facility staff (e.g. chief of post or pharmacists).
‘ . . .at times, they used to sell it [Ivermectin]. Like the pharmacist at the health centre, they
use to sell it, five hundred frs a tablet, I know that it is the left over from the one you people
have been giving. Even the chief of post, the one who was there like that, he used to give her to
sell (CDD, Male, IDI, Cameroon)
Accessibility coverage
Accessibility coverage is concerned with ensuring that services are within reasonable reach of
target populations[23]. We identified that the duration, seasonality and method of distribu-
tion, when not adequately considered have the potential to negatively impact equity in access
to MDA.
Duration of distribution. Timing of both awareness activities and medicine distribution
was a key factor in shaping equity in programme access. Delays in the supply chain, coupled
with stringent reporting structures and timelines from multiple donors, frequently condensed
distribution periods across all contexts. Delays in the supply chain also hindered effective sen-
sitisation campaigns. Consequently, community members either did not know about the pro-
gramme or refused to engage due to lack of knowledge and understanding, thus impacting
accessibility coverage. When poor sensitisation had taken place, community members were
unable to plan to adjust their routines to gain access, or when the time of day that distribution
took place clashed with livelihood or religious activities, specific pockets of the population
were missed, particularly when no “mop-up” took place, again due to lack of medicine avail-
ability or condensed delivery timelines. Across many contexts, it was frequently men who
were absent from communities during delivery due to livelihood activities such as farming, or
fishing being concentrated outside of settlement areas (e.g. men in Ghana were frequently
absent if engaged in small scale mining or fishing activities). Men often reported that if they
had known about the distribution taking place, they would have adjusted their routine; this
raises an important consideration about the flexibility of current MDA approaches to ensure
health interventions do not negatively impact community members.
‘There was no time to mobilize the people; to tell them that we will be on the field on Sun-
day. . .if we were given at least . . .even the distribution, of 5 days, it was small. . .So the five
days we were given for the distribution, if we could get eight days, we could work a lot. . .’
(CDD, Male, IDI, Cameroon)
‘I am not permanently residing in the town, I most often spend my time in the village, so I can
come when necessary. . .I have not experienced people coming here to talk about river blind-
ness, what cause it, I have not experienced it. I have not seen people coming here to talk about
elephantiasis and the causes agent of elephantiasis . . .’ (Community Member, Female, IDI,
Liberia).
‘There's an area in my neighbourhood—I can't lie to you- At [details on location] where I did
not enter. Because the time was too short. That's why we're really asking for time for dis-
tributions. . .’ (CDD, Male, IDI, Cameroon).
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Parents in Liberia and Cameroon described that their children who travelled out of the
community with them while they completed livelihood activities also missed distribution.
Parents in Ghana complained that their children away in boarding schools were always left out
of the exercise and there were no plans by the program to reach them when they finally come
home on vacation. In Liberia and Cameroon, some men suggested that completing awareness
and distribution over the weekend would mean more people would likely be present. However,
in Nigeria, caution was described in completing house to house distribution on Sundays as
most Christians would be absent from their homes. Nevertheless, across Cameroon, Liberia
and Nigeria religious structures were identified as a key structure through which information
or awareness messages could be shared to reach large numbers of the population.
‘But mainly when it is Sunday everyone will be in the town. So, when you make that
announcement Saturday evening, then Sunday the whole place will be park. Sunday is a rest-
ing day, and nobody will be able to go on the farm’ (Community Member, IDI, Male,
Liberia).
‘For most of them who are Christians, you will be lucky to meet them on Sundays, on the
other hand you will be lucky to meet the Muslims on Fridays since they will not go far away
from the vicinity of their mosque’ (CDDs, FGD, Nigeria).
‘we have days of working if you want to see a lot of people. We have Sundays where we can
announce the distribution program in the church and everybody can hear easily’ (CDD, IDI,
Female, Cameroon).
Over ten years of MDA in Ghana and Nigeria, the level of engagement and commitment to
information and sensitization activities at varying levels of the health system has drastically
reduced due to apathy and the assumption that community members are already well
informed. Informants described that despite a long legacy of implementation, the programme
does not consider that populations have changed and increased with younger community
members and inward-migration most of whom do not know the purpose of the MDA and
what the drugs are meant for.
‘Madam, I moved here with my parents three years ago and no one ever told us what the
drugs are for and why we should take them. They just come around and write our names and
ask us to take the drugs for some disease. I have never allowed them to take it because we are
not sure where it comes from.’ (Community Member, Male, FGD, Ghana).
Seasonality of distribution, programme logistics and hard to reach areas. Seasonality
of distribution also shaped programme equity. In Nigeria, Cameroon and Ghana, distribution
during the rainy season leads to inability to reach farming populations as well as placing addi-
tional burden on CDDs due to negative impacts on their livelihood activities. In Liberia and
Ghana during these periods, poor roads and pathways meant that specific communities were
cut off and completely inaccessible to CDDs and therefore whole areas remained untreated. In
addition, lack of equipment such as protective clothing (rain coats and boots) in Liberia and
Ghana compromises the safety and security of the CDDs and makes it very difficult for them
to manoeuvre to the difficult forest areas to reach most farming populations.
‘It was done just as in the past, the only difference being that this year we have gone far into
the raining season before it was distributed. Consequently, the men have already gone off to
their farms and could not access the medicine. Last year the distribution was done earlier as
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such everyone, male and female alike could access the medicine. But this year it was done
deep into the farming season, so it means more men did not access the medicine due to farm
work’ (Older community member, male, FGD, Nigeria)
‘the programme does not consider our health and safety. We do not get even coats or boots to
protect us from the heavy rains and harmful things like snakes and scorpions. We risk our
lives for nothing’ (CDD, Female, IDI, Ghana).
In Cameroon and Nigeria, distribution campaigns that took place during religious fasting
periods also presented a challenge for CDDs. CDDs did not describe these periods as impact-
ing accessibility of MDA, however, it presents challenges for programmes in being able to
accurately record coverage data as directly observing treatment is not possible.
‘. . . there is also a problem because there is this moment of fasting which Muslims observe,
and at that time they are still fasting. . .what can I do? I just have to give them the medicines,
so that when that time reaches [fasting ends] they can then drink it [CDD, Male, IDI,
Cameroon].’
Distribution method. The distribution method used was also of key importance in shap-
ing access to medicines. Participatory community mapping methods utilised across Liberia,
Nigeria and Ghana were a particularly useful easy to use tool in identifying key distribution
methods. Across all contexts, to ensure maximum inclusion of all community members during
MDA both house to house and fixed-point distribution methods were called for by community
members. In Liberia, house to house methods tended to be preferred in some rural areas to
allow CDDs to identify those who were reluctant to take medicines and to ensure appropriate
spread of awareness messaging, in Nigeria and Cameroon it was also indicated to minimise
cost and time for community members; however, in other rural areas fixed point distribution
was preferred as group distribution was thought to have the potential to increase medicine
acceptability. This was particularly true for women who felt more comfortable taking medi-
cines in the presence of their friends. Preferences for fixed point distribution locations varied
across contexts based on geography (urban/rural) as well as religion, and gender, although
clinics, existing community meeting points, religious structures and market places were over-
all, highly favoured. In Cameroon and Nigeria, the Chiefs house was a point for distribution
which worked well where chiefs were popular but could affect access if they were not liked.
. . .some people since they were distributing the drugs in the chief’s palace, they were those who
did not like him, who were not on his side, so they never went there (CDD, Male, IDI, Cameroon)
Accessibility of people living with disability in Nigeria and Liberia was also noted by several
participants who suggested that house to house methods may be better for individuals living
with disability, particularly those with physical impairment who may face mobility restrictions.
In one urban context in Nigeria, some people with disability described that they would prefer
to be treated at spots where they go to beg.
‘‘it is good that the health people always come to our homes with the medicines, but we want
them to set up at the school or market so that anyone who is not at home can get it there”
(Community Member, Male, FGD, Ghana)
‘it is good because other person in the house can’t walk to the place where they schedule their
medicine, so house to house is good’ (Community member, Male, IDI, Liberia).
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‘Sister! it does not cost me anything. . .Mectizan meets me right inside my kitchen and even
inside my bed room without any expenditure.’ (Community member, Female, FGD,
Cameroon)
Acceptability coverage
There were several programmatic factors that shaped acceptability of medicines and conse-
quential equity in attainment of coverage goals. For example, across all contexts, historic mem-
ories of positive programme experiences and perceived benefit of curing sickness (e.g.
expelling worms) were identified as key motivating factors for individuals and communities to
swallow medicines. The role of influential community members in shaping the decision to
accept or reject medicines was also particularly prominent based on gender and generation.
For example, in parts of Nigeria and Cameroon fear within communities that medicines were
a form of family planning often led influential community members to challenge the medicine
provision resulting in women, girls and school-aged children rejecting medicines. In Liberia,
women also described swallowing the medicines because of community leader instruction and
a fear of disrespecting authority.
‘. . .I was refusing to drink Mectizan because they said it aborts pregnancies, I feared drinking
the Mectizan. . .’(Community member, female, IDI, Cameroon)’
‘I’ve got plenty sickness in me, so I just took it maybe it will help you . . .I’ve been taking it
from the time they been bringing it . . .But the past time, the first time never used to. But when
I started taking the drugs this few time even when I reading in the night I can sometime see
clear’ (Community member, IDI, Female, Liberia).
Where community members, or in some parts of Cameroon where the majority of commu-
nities refused to swallow medicines, the main reason was due to observed or experienced side
effects during previous MDA rounds. In some areas of Cameroon where Loa loa is co-endemic
with onchocerciasis, historically, severe adverse events were experienced from taking Ivermec-
tin and so many members refuse MDA because of fear of ‘provoking disease’ or fear of death.
‘I have not been taking because I am afraid because some people say when they take, they get
swollen and others die. So that has made me never to take Mectizan, and I have never taken
Mectizan.’ (Community member, Male, IDI, Cameroon)
Side effects experienced were usually described as itching, swelling or vomiting. Backlash
from communities because of side effects to CDDs and teachers who were inadequately sup-
ported and supervised by the health system was challenging and shaped their willingness and
ability to deliver the programme. In Nigeria, in extreme cases demand for teachers to pay for
medical care needs attributed to MDA instigated significant out of pocket spending in a con-
text of poverty. Strengthening education, awareness and referral around side effects for health
workers and communities would likely increase programme acceptance in these areas. In
Ghana, community members who had experienced side effects complained that when they
report to the health facility with the symptoms, they are not attended to in time and they also
must pay for necessary treatments to manage side effects.
‘It is my policy and the reason why I was refusing to take it. . .Because the first one I took it
make me to feel bad so I look at it I say I scare to take it again because when I take it just like
to say my sickness is coming up . . .The medicines made me to be sick almost one week, when I
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took it my something [scrotum] and my foot swollen and I can go in the latrine fast. . . .No I
took it that’s what I saying I took it but la [it was] the second time that I didn’t took [take] it
. . .It is my policy and the reason why I was refusing to take it’ (Community member, IDI
Male, Liberia).
‘how can you come and give us drugs and when the drugs is causing us problems we don’t
know where to go or who to contact. When we go to the hospitals we are charged for medicines
again to treat us. I will never take this medicine again even if it will give me new life’ (Commu-
nity member, Male FGD, Ghana).
Economic context interacted with medicine side effects to shape acceptance. In the poorest
communities, where children were often sent to school without breakfast, or communities sur-
vived on one meal per day, experience of side effects was exacerbated due to children and com-
munity members having not eaten prior to distribution. In Nigeria, Cameroon and Liberia,
provision of food prior to MDA, sometimes through collaboration with national feeding pro-
grammes or school-based feeding programmes had encouraged the acceptance of medicines
in these communities, meaning the most impoverished individuals were less likely to be lost to
the programme at this stage. In Ghana, community members requested for food to be given to
them before the medicine. Some people recommended that the CDDs should carry some bis-
cuits and drinks so that vulnerable groups such as children and the elderly can have something
to eat before the medicine is given especially in very impoverished communities. In Nigeria,
some CDDs carried water with them (purchased themselves) to encourage community mem-
bers to accept the medicines. Directly observed treatment became of critical importance when
food or water was also distributed with medicines, otherwise there were reports of some com-
munity members accepting but not swallowing medicines in order to receive food and water.
‘Children came to take the medicine because of the school feeding program knowing fully well
they will get to eat before or after taking the medicine, but [a] few their parent forbid them
from taking the medicine, I witnessed some children after eating the food and giving the medi-
cine, they kept it in their mouth and spit it out later on but we recorded a great success here’
(Teacher, Nigeria).
‘the health sector should provide food for us before we are given the drugs. The CDDs can
carry some biscuits and malt to give to the children and old people so that they can be strong
to take the medicine’ (Community member, Male IDI, Ghana).
Fear of side effects creating additional economic pressures was found in Cameroon. Men
feared that side effects would limit livelihood activities and some community members feared
side effects would lead to healthcare costs that families could not afford.
Delivery mechanisms also interacted with traditional belief systems to shape programme
acceptance, for example, in some parts of Liberia, and in Islamic areas in Nigeria, community
members, particularly women, described a preference for not being measured using a stick
and suggested that a different way of measurement would increase medicine acceptance as
sticks are also used to measure corpses. Finally, historic experiences that led to a breakdown in
trust between health systems and communities influenced medicine acceptance. For example,
in Liberia, during the Ebola outbreak, community members described being told not to take
medicines from anyone, so they refused these medicines due to a lack of additional awareness
activities. In very few cases, some participants also described a perception that the medicines
were bringing Ebola. However, some mothers and fathers described an increased likelihood to
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accept medicines in future MDA rounds due to the follow up visits CDDs made to their chil-
dren during this distribution period to alleviate these fears.
‘Well this world we living in everybody want good thing about themselves, even though this
time we are skeptical in taking the tablet because the Ebola that broke out people said that
people were doing bad things about it that even if you are healthy as soon as you take the tab-
let then you become weak (Community member, Female, IDI, Liberia).
Contact coverage
Contact coverage is determined by the number of people who have contacted the service, that
is those people who come into direct contact with the service provider[23]. Contact coverage
between those delivering the service and those who we hope to receive it is essential, however,
community power relations are of critical importance in determining how this interaction
takes place, thus impacting intervention equity. CDDs are usually the main distributor during
MDA. Across all communities and contexts, the way in which CDDs were selected was of
importance in shaping interactions with the distribution programme. Many communities
wanted to be involved in selection of who it was who would distribute the medicines to them
and prioritised factors such as belonging to the community, having some prior knowledge of
health or drug distribution methods and having links with the local clinic.
‘somebody must be attached from the health facility before that person can be given the chance
to carry out medication around. . .’ (Community member, female, IDI, Liberia).
Across all contexts, more CDDs were described as necessary to reach the whole population,
but funding shortages and limitations (as described in the context and commonality section)
had reduced the number of CDDs that the programme was able to engage.
‘When we started MDA, we used to have one or two CDDs per community depending on the
size. These days there is one CDD for over ten communities. How can they reach everywhere?
It is not possible. . .’ (sub-district health officer, IDI, Ghana)
CDD selection processes are frequently linked to gender norms, power and patriarchy
within communities and households and needs to be negotiated carefully in programme design
and delivery. Across multiple contexts, it was identified that the gender of CDDs shaped interac-
tions at household level and may lead to some members of the household, particularly women,
being untreated and invisible within programme reporting structures. For example, in parts of
Nigeria, where male CDDs cannot enter the household to distribute medicines to females with-
out the household head being present, some females were left untreated. This also presents chal-
lenges in ensuring accurate census estimates (when the census occurs) i.e. due to the recording
process CDDs undertake, it is possible that if they don’t enter the household, members of the
household could become ‘missing’ within data sets recorded in the CDD register.
‘it means that the men cannot enter the houses even though they are members of the commu-
nity and were selected by the community most men would not want another man to see their
women. This means that if the head of the household is not at home, those people won’t get
medicines. . .’ (LGA Health Staff, IDI, Nigeria).
Patriarchal decision-making structures across many contexts, also shaped autonomy in
decision making for many community members as described in the acceptability section
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above. In addition, in northern Nigeria, CDDs also reported that in cases where it was a house-
hold head who has not seen benefits to the medicine, they sometimes, in addition to not taking
the drugs themselves, prevented other household members from taking them. This was also
experienced in Cameroon where household heads did not trust distribution campaigns as they
were linked to the government. In this way, the lack of benefits or trust by one person would
have a disproportionate impact on coverage.
‘I have an issue with a particular household. I was told that for the past two years, they have
refused to accept the drugs. The head of the family says he has not seen any benefit for taking
the drug and in turn has stopped the rest of his household from taking the drugs’ (CDD, FGD,
Nigeria).
Contact coverage for CDDs was also described as compromised when trying to reach spe-
cific population groups including nomadic or transient groups and those living in security
compromised areas. Strategies to ensure nomadic and transient groups were identified as:
ensuring engagement of health workers from within those areas; recruitment of CDDs from
within these populations to encourage their support in programme design and delivery; as well
as the lengthening of distribution periods so that nomadic or transient groups may receive
treatment when they meet more ‘static’ populations.
‘I have been now for 15 years and the only people who posed a challenge were the Fulani peo-
ple who move about the country so when they come back they would have increased, or
another separate group will come back. This has made it difficult in time past, so some people
will not get the drugs. Now however we have CDDs among them who work with those of us
who don’t move around like they do’ (CDD, FGD, Nigeria).
In Nigeria, in urban areas residents came out to take the medicines having seen that it was
community health extension workers in uniform that were completing the distribution. In
some cases, this encouraged those who had refused the medicines previously to swallow the
tablets as health workers were trusted to have professional training to carry out health inter-
ventions. For instance, some residents felt that they ‘have adequate knowledge about what they
are doing, and it was not that they gave out the medicine to just anybody’. This contributed to
improved treatment coverage in those places as parents also allowed their eligible children to
take the medicines.
Effective coverage
Effective coverage is achieved when all those who are eligible to receive the service have had
equitable opportunity to obtain treatment. In treating persons living with disabilities, across
most contexts, CDDs and programme implementers described trying not to discriminate in
determining who they delivered the medicines to and followed guidelines closely. However,
they identified that this was a challenge when it came to the treatment of people living with dis-
ability (e.g. epilepsy or people who were unable to stand). These scenarios were not covered in
their training or there were reports of inconsistent advice or guidelines given by different
trainers.
‘For the physically disabled, they are told to stand on crutches and measurements made then
we give the appropriate drug sometimes, at other times we just don’t give them’ (State Health
Staff, IDI, Nigeria).
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Additionally, health workers or CDDs faced difficulties establishing pregnancy status of
women, either because enquiry about pregnancy sometimes offended husbands or where
women were not aware they were pregnant. There was concern that if pregnant women were
not successfully excluded from treatment they miscarry because of the drugs. This resulted in
some of these individuals being included and some excluded depending on the circumstance
and on a case by case basis. For pregnant women not included in distribution or for those who
are sick based on medical grounds, across all contexts, no mechanism for follow up of these
populations following MDA campaign periods was identified. Some women who are pregnant
or lactating for multiple distribution rounds and those who are chronically sick who in some
contexts are perceived as ‘ill’ (for example people living with HIV/AIDS) may, therefore, be
constantly missed and thus more vulnerable to ongoing infection or increased morbidity.
There is a need to think through innovative strategies to reach these populations outside of
routine campaign periods.
Policy decisions such as school-based treatments, can also render coverage ineffective for
specific populations who need medicines but are not considered within programme design, as
described in the accessibility section above.
Discussion
The importance of intersectional gender analysis in evaluating coverage
frameworks on the pathway to UHC
Coverage frameworks that allow for consideration of all health systems factors and recognise
the limitations of service provision are clearly important. However, when used in isolation
they can mask underlying power dynamics that result in inequitable intervention outcomes.
There have been few papers to date that use in-depth qualitative research across multiple coun-
tries that explore the equity of MDA. To our knowledge this is the only paper which has com-
bined a comprehensive equity framework (the Tanahashi Framework) with intersectional
feminist theory, to establish a fuller understanding of who is left behind and why in MDA in
different contexts. The diversity of contexts strengthens the rigour of our analysis and enables
critical perspectives of communities and health systems actors from different country contexts.
We were also able to compare differences and similarities across and within country contexts
that add value to the complexities of MDA delivery uncovered through an intersectional analy-
sis, including adaptations required based on geography (urban and rural), religion (Islamic
and Christian), post-conflict and fragile settings. Whilst presenting a nuanced account of the
depth and detail from every context was not always possible, throughout our analysis we have
drawn on the rich contextual understandings of our authorship team and more nuanced
accounts of findings can be found in associated published [32] and forthcoming briefs and
articles [33–38]. In interpreting the findings presented here, it should be recognised that most
of the study team occupy positions as ‘outsiders’ within study communities as may be per-
ceived as occupying relative positions of power in comparison to research participants due to
their social position. Although this is true within many research studies, we took several steps
to minimise power imbalances. Throughout the data collection process everything was done
to build rapport and trust with participants, particularly those perceived to be the most ‘vul-
nerable’, however, it is still likely that some participants did not feel able to disclose all parts of
their experience. Researcher positionality may have also shaped interpretation of participant
responses. Participatory dissemination activities with stakeholders at varying levels of the
health system were completed to triangulate data interpretation and encourage additional
sharing of experience, however this may not have fully mitigated this challenge.
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Our findings show that who is missed in MDA is often determined by underlying power
dynamics which shape programme delivery structures and intersecting axes of inequity which
may vary in different contexts. Acting to address these power imbalances in the delivery of
MDA is essential to ensure equitable attainment of service delivery goals and to contribute
toward the attainment of UHC. We present the convergence of these factors within Fig 2.
The outer circle of our adapted Simpson’s intersectionality wheel [39], emphasises our find-
ings that donor dependency can limit the flexibility and autonomy of programmes; dominant
forces of privilege and oppression shape who is hidden and who is acknowledged; conflict and
fragility; political alliances and economic factors influence who can access medicines, where
and when; and that the historic legacy of programmes can limit innovation due to the ‘normal-
isation of processes’. The impact of these factors on effective treatment outcomes for individu-
als and communities is of course also influenced by individual identities and the intersecting
axes of inequity that converge to shape these positions including gender, age, dis/ability, eth-
nicity, and geography. Health systems are inherently social [40, 41] and gendered [42] thus
they become critical mediators in managing the impact that social and structural processes
have on individual health outcomes. We identified that health systems bottlenecks, challenges
and limitations, sometimes due to lack of consideration and discussion of gender and equity
issues have left vulnerable populations underserved in relation to the prevention and treatment
of PC NTDs across all types of coverage explored within the Tanahashi framework.
Availability coverage can be compromised due to: medicine shortages and delays because
of poor requisition estimates and weak supply chain, leading to key populations being missed
based on ethnicity (e.g. migrant groups) or religion; policy or programmatic engagement can
mean out-of-school children or children in religious schools are missed, showing interlinkages
between programme and education structures; and out of pocket payments for frontline health
providers can render MDA impoverishing for those delivering drugs within communities.
Fig 2. Adapting Simpson’s[39] intersectionality wheel to show how social and contextual factors interact and are mediated by health systems factors to shape
equity of NTD programme delivery.
https://doi.org/10.1371/journal.pntd.0007847.g002
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Accessibility coverage is hindered by the interconnection of geography, economic factors and
unadaptable health systems both in urban and rural settings which can lead to context specific
inequities: men were frequently left out of distribution due to condensed distribution periods
and absenteeism from communities based on livelihood or economic activities; seasonality of
distribution meant that some entire communities, in the most isolated settings, were excluded
from distribution, showing an interaction between restrictions to programme adaptability,
geography and economic factors; and limited flexibility in distribution strategies can restrict
access to interventions for people living with disability, women, and men, as well as those liv-
ing in urban areas. Acceptability of medicines is frequently influenced by: restrictions to
autonomous decision making based on gender, age, and religion; socio-economic context (i.e.
wealth and poverty) and availability of food can influence the experience of side effects and
thus interconnects to shape programme acceptance; and traditional belief systems that are not
considered in programme design e.g. the use of sticks for measurement can shape the accept-
ability of the intervention. Contact coverage is frequently impacted by patriarchal decision-
making structures which determine who are CDDs as well as who CDDs can interact with.
This can result in many women being untreated, or unrecognised by the programme. Finally,
effective coverage is negatively influenced when pregnant women, people with disabilities,
and the chronically sick are frequently left out of programme delivery due to programmatic
campaign structures and definitions of ‘ill health’.
Although policy and practice goals e.g. those laid out in the NTD 2020 declaration do not
require 100% MDA coverage, instead aiming for between 65% (lymphatic filariasis) and 75%
(soil transmitted helminths and schistosomiasis for school aged children) [3], from an equity
and ethical perspective this brings challenges. Ultimately, sections of the population are missed
and as the combined application of the Tanahashi framework and intersectional analysis
shows, it is consistently those experiencing intersecting vulnerabilities that are missed. As an
NTD community we need to think beyond the ultimate coverage goal and begin to breakdown
the different elements of coverage to understand who is left behind and why. In understanding
this, we can begin to think about who it is we need to target to go the ‘extra mile’ to reach
those who need it the most and in supporting the remaining steps toward NTD elimination
[12, 19, 43, 44]. This would contribute to the progressive realisation of UHC by prioritising the
‘worst off’ [11], thus truly supporting the NTDs communities’ ambitious vision to contribute
to UHC attainment and the SDGs. Arguably, it is only when the fundamental right for all to be
able to access prevention and treatment for PC NTDs is recognised and realised by the NTD
and wider global health community, that PCT NTDs can become a true ‘litmus test’ for UHC.
So, what does this all mean for programme delivery, integration into
routine health systems and UHC?
There are key nuances in equity challenges across contexts, however, our collective analysis
emphasises that there are core common issues that require action. There is a key need for
multi-pronged strategies to address inequities within NTD programming, ensuring UHC
through the equitable attainment of development priorities whilst maximising social inclusion
and cohesion [45]. Such strategies should respond to power dynamics at varying levels includ-
ing at the local, national and global level.
Local level: Community participation and accountability to challenge
power relations
Meaningful community participation strengthens public accountability which is a critical step
on the pathway to achieving UHC as it allows for health systems and or health intervention
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reform to be guided by the needs and values of a broad range of stakeholders, not just the most
powerful[11, 46]. The consistent strength of community ideas (embedded within the realities
of different contexts) to improve programmes supports this notion and emphasises the origi-
nal ethos of NTD programming that communities have the knowledge to be able to guide and
design the way that programmes are delivered [43]. However, as shown by others[47, 48], in
contrast to previous times, communities are now less frequently consulted and thus the effec-
tiveness of interventions can be compromised. We found this to be particularly the case in
relation to accessibility and acceptability coverage due to programme weaknesses in the gener-
ation of awareness and knowledge about services as well as limited adaptability in the methods
for medicine distribution and campaign timing. Rapid levels of urbanisation [49], coupled
with increased pockets of fragility and conflict [50] mean that now, more than ever, the flexi-
bility and responsiveness of MDA approaches is essential to reach those who are most in need
[20]. We therefore need to begin to think critically about how to re-engage communities in dif-
ferent ways and across a variety of contexts, including the most fragile, to ensure that health
systems and interventions are held to account to the needs of the most vulnerable.
Responses must draw on evidence such as that presented here and continue to seek the
views and opinions of the most marginalised. Implementation research can provide a space for
such evidence informed decision making, and when facilitated effectively can contribute to
breaking down power hierarchies between communities and health systems to support in the
development of mutual trust and accountability [10]. For example, as shown here, trust in the
health system and distributors is critical to improving acceptability coverage, however MDA
campaigns tend to sit on the periphery of the health system due to a history of ‘chronic vertica-
lization’[51]. Whilst there is evidence that community leaders were engaged in some contexts,
there were still clear gaps in understanding the best way to ensure all community members
were engaged, particularly those who experienced marginalisation based on intersecting ineq-
uities. Implementation research has the potential to understand accountability structures
across contexts, such as health committees and other community-based health units, which
can support in decreasing inequities as they frequently engage with vulnerable groups and can
support in the provision of community-based supervision. Understanding how to embed
MDA campaigns within existing social accountability frameworks will also ensure MDA cam-
paigns that are better integrated within the health system[52].
National and sub-national level: Supporting intersectional analysis within
programmes and enhancing workforce support
At the national and sub-national level, a critical first step to ensure programmatic responsive-
ness to equity issues is to prioritise the collection of both quantitative and qualitative data.
Cohn et al 2019, emphasised that the collection and use of quality quantitative gender disag-
gregated data is possible, but that accompanying qualitative analysis allows us to obtain a better
understanding of ‘whether, how and to what benefit countries have used such data to
strengthen programmes’[12]. Health systems must be responsive to changing contexts such as
growing urbanisation, changing livelihood patterns, growing fragility and insecurity and
unstable political contexts [20, 21]. Space and time within intersectional analysis is a key factor
that influences service provision and acceptance and should be built into to annual pro-
gramme reviews to address change. We need, therefore, to now also consider how gender dis-
aggregated data can be consistently linked to other markers of social inequities such as age,
gender, wealth and dis/ability to routinely consider and address the impact of intersecting vul-
nerabilities within the broader socio-political context. Quantitative data in isolation can mask
significant programme inequities or present varying outcomes. WHO’s toolkit ‘Towards
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universal coverage for preventive chemotherapy for Neglected Tropical Diseases: guidance for
assessing “who is left behind and why”?’ is designed to take the initial step toward supporting
NTD programme managers to begin to collect and analyse both quantitative and qualitative
indicators to support ongoing equity analysis [7], however a question remains regarding the
feasibility of this approach for an already overstretched health workforce. New technologies,
information systems and innovations are also required to support health system responsive-
ness [18].
CDDs, as a type of community health worker (CHW), are a critical asset to all NTD pro-
grammes in supporting the negotiation of community power dynamics [53, 54], and serve as a
key bridge between health systems and the populations to whom they are seeking to provide ser-
vices. However, for NTD programmes to maximise the benefits that CDDs can provide in nego-
tiating power within communities, policy makers and implementers need to consider gender
and equity dynamics in conceptualising the CDD role within MDA. This includes thinking
through how to manage the power dynamics associated with CDD selection as well as how gen-
der roles and relations and other equity considerations shape individual experience of being a
CDD so that they can be effectively supported [53]. Gender and equity reviews of NTD policies
and programmes in specific relation to CDDs would be a critical first step in supporting pro-
grammes to adapt to community and individual level power dynamics. Specific training modules
or activities could also be integrated within CDD and health worker MDA training processes to
support these health cadres to be more responsive to power dynamics at the community level
and in encouraging them to become agents of gender and equity transformation [8, 54].
Historical experience of side effects and severe adverse events as described in other studies
[19, 43, 44, 47] were a key factor in reducing programme acceptance and presented a multitude
of challenges for programme implementers, including teachers. The national and sub-national
level must respond to support its workforce to manage these challenges. Consideration of a
well-designed system for reporting of side effects and adverse events (including severe), would
not only support frontline health workers to respond to these situations but also support in
increasing acceptability coverage of interventions. The establishment of clear pharmacovigi-
lance guidelines in Nigeria has been shown to be effective in this regard [48].
Global level: Redressing power imbalances within the international NTD
community
Finally, at the global level, power imbalances between donors, implementing partners and
national programmes can limit the autonomy of national actors to be able to respond to needs
within their own context. Such limitations to programme adaptability have been shown here
to reduce the equity in intervention outcomes, thus the time is now for donors and imple-
menting partners to consider collective action to redress these imbalances. The NTD funding
landscape is in a period of transition with the initiation of the DFID funded ‘Accelerating the
sustainable control and elimination of NTDs (ASCEND)’ and US AID funded ‘Act to End’
programmes. This together with UHC aspirations to tackle inequality and inequity presents a
clear window of opportunity to redress power imbalances amongst the international NTD
community. This could be leveraged through adaptations to stringent MDA timings or report-
ing deadlines; and some flexibility in campaign structure so that specific populations e.g. preg-
nant women, the chronically ill, and migrant communities can be reached outside of
campaign periods, through for example, some medicines being left in health centres to allow
for longer term ‘mop up’. Sustaining access to treatment over longer periods for these popula-
tions would likely contribute to reduced morbidity burdens associated with these diseases that
will remain even after ‘elimination’ when active transmission ceases.
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As we move towards the progressive realisation of UHC, these findings should be central to
discussions on providing health for all. MDA campaigns have been implemented for many
years and the inequities within them are only now being discussed. The lessons from PC-NTD
programmes should be heeded by UHC actors who can build in intersectional analysis from
the beginning, from selecting services to prioritising how to deliver them. However, for the
NTD community to continue to support their vision of being a true ‘litmus test’ for the attain-
ment of UHC, they must continue to seek to understand how to make their programming
more equitable across all levels of coverage to ensure that the most vulnerable have continued
access to future treatment options.
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